Section

Markets

Start here Bond vs loan: two routes to borrowing Commercial paper is a company’s short-term promise to repay Market liquidity and the cost of trading Bond yields show the return investors demand for lending

TipRanks-tracked analysts maintained buy ratings on Amazon, Marvell and AMD, with cloud and data-center AI demand central to their...

By Marcus V. Thorne 1 month ago

Central Command said the latest U.S. strikes followed an Iranian attack that disabled a Cyprus-flagged container ship in the Strai...

By Sarah Jenkins 1 month ago

Graham’s office said the senator died after a brief, sudden illness, ending a Senate career that began with his 2002 election.

By Sarah Jenkins 1 month ago

Chip and Meta gains helped the Nasdaq and S&P 500 rise, while renewed U.S.-Iran tensions pushed crude higher and weighed on the Do...

By Amanda Ross 1 month ago

ETF Action’s Mike Akins told CNBC that lagging software, cloud, disruptive tech and Magnificent Seven shares could regain ground a...

By Amanda Ross 1 month ago

The Hangzhou startup is pursuing non-invasive brain-computer interfaces as China puts neurotechnology into its industrial policy f...

By Sarah Jenkins 1 month ago

The new 530A accounts offer tax-deferred investing for minors, with federal seed money for some newborns and annual contribution l...

By Sarah Jenkins 1 month ago

CNBC’s 2026 study gave quality of life greater weight as employers weigh talent access, health, safety and childcare in location d...

By Amanda Ross 1 month ago

Self-optimization trends are spreading as the wellness economy grows, but clinicians say extreme goal-setting can worsen anxiety,...

By Amanda Ross 1 month ago

The 21st Century ROAD to Housing Act became law without President Trump’s signature, targeting supply, financing access and instit...

By Marcus V. Thorne 1 month ago

Berkshire Hathaway’s B shares are down 1.8% in 2026, while the S&P 500 is up 10.7%, according to CNBC calculations.

By Sarah Jenkins 1 month ago

Novo Nordisk has agreed to evaluate Vivani’s experimental semaglutide implant, a long-acting device still awaiting human trial dat...

By Marcus V. Thorne 1 month ago